{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:23:27Z","timestamp":1771640607519,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":9299,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1982,10]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>To determine whether the improvement in clinical status of patients with active acromegaly correlates with a reduction of circulating somatomedin\u2010C, serum immunoreactive somatomedin\u2010C was measured in twenty\u2010seven patients before and during bromocriptine therapy. The patients were assessed using a clinical and metabolic score which included both subjective criteria of improved sweating and facial features, and objective criteria of a reduction in ring circumference and the area under the glucose tolerance curve. Using this, together with the change in GH levels before and during bromocriptine therapy, the patients could be divided into three groups. In one group, there was no clinical improvement, a less than 30% decline in somatomedin\u2010C, and in four of six patients no significant decline in GH. In both the other groups there was clinical improvement and a greater than 30% decrease in somatomedin\u2010C. In one of these two groups, however GH did not decline, while in the other it was reduced significantly. The results suggest that during bromocriptine treatment of acromegaly, serum somatomedin\u2010C concentrations correlate better with clinical status than does serum GH. Since some patients have no significant fall in GH but show both clinical improvement and a reduction in somatomedin\u2010C, it seems likely that in some patients bromocriptine may improve acromegaly by a mechanism other than a simple decrease in total immunoreactive GH secretion.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1982.tb01602.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T12:56:02Z","timestamp":1205758562000},"page":"369-377","source":"Crossref","is-referenced-by-count":59,"title":["CHANGES IN CIRCULATING SOMATOMEDIN\u2010C LEVELS IN BROMOCRIPTINE\u2010TREATED ACROMEGALY"],"prefix":"10.1111","volume":"17","author":[{"given":"J. A. H.","family":"WASS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. R.","family":"CLEMMONS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. E.","family":"UNDERWOOD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"BARROW","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"BESSER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J. VAN","family":"WYK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000179050"},{"key":"e_1_2_1_3_1","first-page":"695","article-title":"Bromocriptine treatment of acromegaly","volume":"45","author":"Besser G.M.","year":"1976","journal-title":"Quarterly Journal of Medicine"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/014107687907200804","article-title":"Bromocriptine and acromegaly: therapeutic implications","volume":"72","author":"Brooks A.P.","year":"1979","journal-title":"Journal of the Royal Society of Medicine"},{"key":"e_1_2_1_5_1","first-page":"469","article-title":"Response of acromegaly to long\u2010term bromocriptine therapy: a biochemical and clinical assessment","volume":"89","author":"Clayton R.N.","year":"1978","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197911223012102"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90470-2"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-50-4-690"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-19-7-743"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-4-781"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-48-6-931"},{"key":"e_1_2_1_12_1","first-page":"213","article-title":"Studies on the bioassayable growth hormone\u2010like activity of plasma","volume":"34","author":"Ellis S.","year":"1978","journal-title":"Recent Progress in Hormone Research"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5768.225"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108816"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-43-2-364"},{"key":"e_1_2_1_16_1","first-page":"464","article-title":"Bromocriptine treatment in acromegaly: clinical and biochemical effects","volume":"86","author":"Halse J.","year":"1977","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-39-2-257"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-45-5-988"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1978.tb01349.x"},{"key":"e_1_2_1_20_1","first-page":"409","article-title":"Clinical and laboratory study of acromegaly: assessment before and one year after treatment","volume":"43","author":"Kanis J.A.","year":"1974","journal-title":"Quarterly Journal of Medicine."},{"key":"e_1_2_1_21_1","first-page":"477","article-title":"Human growth hormone: a complex of proteins","volume":"36","author":"Lewis U.J.","year":"1980","journal-title":"Recent Progress in Hormone Research"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198106113042402"},{"issue":"216","key":"e_1_2_1_23_1","first-page":"207","article-title":"Bromocriptine therapy in eleven patients with acromegaly","volume":"88","author":"Lundin L.","year":"1978","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-47-1-110"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000179121"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-81-6-781"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00239229"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1159\/000179113"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.0820449"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198110293051816"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6065.875"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb03132.x"},{"issue":"216","key":"e_1_2_1_33_1","first-page":"199","article-title":"Bromocriptine therapy in patients with acromegaly: Effects on growth hormone, somatomedin\u2010A and prolactin","volume":"88","author":"Werner S.","year":"1978","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_34_1","first-page":"289","volume-title":"Somatomedins and Growth","author":"Wiedemann E.","year":"1979"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1982.tb01602.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1982.tb01602.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T16:49:00Z","timestamp":1699721340000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1982.tb01602.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,10]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1982,10]]}},"alternative-id":["10.1111\/j.1365-2265.1982.tb01602.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1982.tb01602.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,10]]}}}